Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.


Census Bureau: Uninsured Rate Fell to 8.7% Last Year; 66,000 More Jerseyans Insured

Washington, DC, September 13, 2017 — Louise Radnofsky reports in The Wall Street Journal that the share of people in the U.S. who lacked health insurance for the whole of 2016 declined to 8.8 percent, the Census Bureau announced Tuesday.

This was down from 9.1 percent the previous year, largely due to Americans aging into the federal Medicare program for people 65 and older.

The rate reflects around 28.1 million people without health coverage, a decrease from 29 million a year earlier, hitting a new low that has also been reflected in other government and private surveys. Continue reading

HHS Report: Medicare Shared-Savings ACOs Cut $1 Billion in Costs Over Three Years

Washington, DC, September 5, 2017 — Shelby Livingstone reports in Modern Healthcare that accountable care organizations (ACO) participating in the CMS’ Medicare shared-savings program reduced spending by about $1 billion in three years, the Department of Health and Human Services’ (HHS) Office of Inspector General reported Tuesday.

Most of the 428 ACOs in the first three years of the shared-savings program reduced Medicare spending compared to their benchmarks, and a small group of those ACOs produced “substantial” savings.

The majority of the ACOs—82%—also improved the quality of care they provided, based on data from the CMS on 33 individual quality measures. They outperformed fee-for-service providers in 81% of the quality measures. Continue reading

CMS Announces Average Medicare Part D Drug Premium Expected to Dip in 2018

Washington, DC, August 4, 2017 — The Centers for Medicare & Medicaid Services (CMS) on August 2 announced that the average basic premium for a Medicare Part D prescription drug plan in 2018 is projected to decline to an estimated $33.50 per month.

This represents a decrease of approximately $1.20 below the actual average premium of $34.70 in 2017.

Some 43 million seniors have Medicare “Part D” prescription coverage. Continue reading

Opinion: NJAMHAA Mary Abrams Urges NJ’s Members of Congress to Reject GOP Interference with Medicare Part D

New Brunswick, NJ, July 13, 2017In a Star-Ledger opinion piece published on July 12, Mary Abrams, Senior Health Policy Analyst at the New Jersey Association of Mental Health and Addiction Agencies (NJAMHAA), writes:

Congress could soon weaken prescription drug coverage for more than 900,000 New Jersey residents.  Lawmakers want to fundamentally alter Medicare Part D, which has provided seniors and the disabled with affordable medicines for more than a decade.

The program has become a lifeline.  Without Part D, nearly two out of three seniors say that they would be unable to fill all of their prescriptions, while one in two say that they would be more likely to cut back or stop taking their medicines altogether. Continue reading

Study: Mortality Rates for Elderly Have Decreased Every Year Since Creation of Medicare Part D

Washington, DC, July 11, 2017 — Nicole Longo reports that on PhRMA’s blog’s, The Catalyst’s, weekly “Medicare Monday” feature that “we’ve talked about how Medicare Part D’s competitive structure improves access to affordable prescription drug coverage for seniors and individuals with disabilities.”

“We’ve also talked about the positive impact Part D has had on America’s seniors. Today, we’re diving into how Part D has impacted mortality rates for seniors.”

In case you missed it, a recent study from the University of Illinois at Urbana-Champaign found that mortality rates for the elderly have decreased every year since the Part D program was implemented in 2006. Continue reading

PhRMA: New Study Further Confirms Increased Use of Generics After Part D

Washington, DC, April 2, 2017Pharmaceutical Research and Manufacturers of America (PhRMA) has written a lot about how things have changed since 2006 and the implementation of Part D.

PhRMA has looked at how Part D costs less than originally projected, how premiums have remained steady and how competition has worked to keep costs low.

In addition, PhRMA has highlighted what the Medicare Trustees report has shown, that there has been a steady increase year after year in the generic utilization rate for Part D beneficiaries. Continue reading

Study: Medicare Prescription Drug Benefit Reduced Elderly Mortality by 2.2 Percent

Champaign, IL, March 15, 2017 — A new paper co-written by a University of Illinois expert in health care economics provides the first evidence that the increase in drug utilization attributable to Medicare Part D saved lives.

The implementation of Medicare’s prescription drug benefit program has reduced elderly mortality by 2.2 percent annually since 2006, according to an analysis by Julian Reif, a professor of finance and of economics at Illinois.

“A big question in health economics is ‘Do public health insurance programs improve people’s health?’” said Reif, also a faculty member of the Institute of Government and Public Affairs and the Center for Business and Public Policy. Continue reading

Seema Verma Confirmed as Director of Centers for Medicare & Medicaid Services

CMS Director Seema Verma

Washington, DC, March 14, 2017 — The Senate on Monday confirmed President Donald Trump’s nominee, Seema Verma, to serve as the director of the Centers for Medicare and Medicaid Services (CMS), Indiana health care consultant Seema Verma.

Verma was confirmed 55-43 in the Senate Monday evening.

During her confirmation hearings, Verma said that she does not support turning Medicare, the government’s program for adults over 65 and people with disabilities, into a voucher plan in which people would select coverage from private health insurance companies. Continue reading

HHS Sec. Price Says Administration Believes in the ‘Guarantee of Medicare for Our Seniors’

HHS Secretary Tom Price

Washington, DC, March 6, 2017 — As President Donald Trump and congressional Republicans debate the future of Medicare, Health and Human Services Secretary Dr. Tom Price said Sunday that Republicans “believe in the guarantee of Medicare for our seniors.”

His comments come after President Donald Trump reiterated during his address to a joint session of Congress last week that he doesn’t want to change Medicare benefits. Meanwhile, House Speaker Paul Ryan has said he still thinks the future of Medicare is an “open question.”

“I’ll tell you what’s not an open question, is that we believe in the guarantee of Medicare for our seniors,” Price told CBS’ “Face the Nation.” Continue reading

New Jersey Policy Perspective Reports: An Obamacare Repeal Without Replacement Will ‘Devastate’ the Garden State

Trenton, NJ, February 22, 2017 — According to a new report from the New Jersey Policy Perspective, if Congress repeals the Affordable Care Act (ACA) — well known as Obamacare — and doesn’t replace it, the loss of coverage for an estimated 800,000 New Jersey residents would be only part of the story, reports Lindy Washburn in The Record/NorthJersey.com.

The report presents county-by-county data about the effect of ACA repeal.

In addition, Livio reports that more than 210,000 seniors who rely on Medicare and have substantial prescription drug needs would face higher out-of-pocket costs. Continue reading